A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea
Clinical trial NCT03416855 · COMPLETED
Trial details
- NCT number
- NCT03416855
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-31
- Primary completion
- 2020-05-19
- Enrollment
- 768
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.